Dezima Pharma Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

Dezima Pharma General Information

Description

Developer of novel drugs intended to treat dyslipidemic patients suffering from cardiovascular disease. The company develops a cholesteryl ester transfer protein inhibitor that acts as a pharmacological therapy to lower low-density lipoprotein cholesterol and hence lower cardiovascular disease, thereby enabling clinicians to treat dyslipidemic patients.

Contact Information

Website
www.dezimapharma.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Gooimeer 2 - 35
  • 1411 DC Naarden
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
NewAmsterdam Pharma Company
Vertical(s)
Life Sciences
Corporate Office
  • Gooimeer 2 - 35
  • 1411 DC Naarden
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dezima Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dezima Pharma‘s full profile, request access.

Request a free trial

Dezima Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel drugs intended to treat dyslipidemic patients suffering from cardiovascular disease. The company deve
Drug Discovery
Naarden, Netherlands

San Francisco, CA
 

Bresso, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dezima Pharma Competitors (19)

One of Dezima Pharma’s 19 competitors is Theravance Biopharma, a Corporation company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Theravance Biopharma Corporation San Francisco, CA
The Zambon Group Private Debt Financed Bresso, Italy
Verona Pharma Private Debt Financed London, United Kingdom
Pulmatrix Formerly VC-backed Framingham, MA
Ability Pharma Private Equity-Backed Barcelona, Spain
You’re viewing 5 of 19 competitors. Get the full list »

Dezima Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Dezima Pharma‘s full profile, request access.

Request a free trial

Dezima Pharma FAQs

  • When was Dezima Pharma founded?

    Dezima Pharma was founded in 2012.

  • Where is Dezima Pharma headquartered?

    Dezima Pharma is headquartered in Naarden, Netherlands.

  • What industry is Dezima Pharma in?

    Dezima Pharma’s primary industry is Drug Discovery.

  • Is Dezima Pharma a private or public company?

    Dezima Pharma is a Private company.

  • What is Dezima Pharma’s current revenue?

    The current revenue for Dezima Pharma is .

  • How much funding has Dezima Pharma raised over time?

    Dezima Pharma has raised $19M.

  • Who are Dezima Pharma’s investors?

    Amgen, BioGeneration Ventures, Forbion, and New Science Ventures have invested in Dezima Pharma.

  • Who are Dezima Pharma’s competitors?

    Theravance Biopharma, The Zambon Group, Verona Pharma, Pulmatrix, and Ability Pharma are some of the 19 competitors of Dezima Pharma.

  • When was Dezima Pharma acquired?

    Dezima Pharma was acquired on 01-Apr-2020.

  • Who acquired Dezima Pharma?

    Dezima Pharma was acquired by NewAmsterdam Pharma Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »